THE CURELINE GROUP and Cellecta Inc LAUNCH TISSUE TO TARGET STRATEGIC PARTNERSHIP INITIATIVE Brisbane, CA, and Mountain View, CA–(PRNewswire)–October XX, 2022 The Cureline Group and

An estimated 20,000 new cases of ovarian cancer will be diagnosed in 2022. While rare in women younger than 40 years old, around 50% of

It has been an exciting journey for the Cureline Group, from the time CEO Dr. Olga Potapova spearheaded the establishment of the company in 2003,